--- title: "160 Health Expands “160AI Hospital” Network to 102 Public Institutions in China" type: "News" locale: "en" url: "https://longbridge.com/en/news/283409246.md" description: "160 Health International Ltd. has expanded its \"160AI Hospital\" collaboration model to 102 public medical institutions in China, up from 82. This includes 54 Class IIIA hospitals, indicating strong traction in the high-end segment. The partner hospitals handle approximately 84.37 million outpatient visits and generate around RMB99.7 billion in revenue annually. The company is accelerating the deployment of its AI systems to enhance clinical workflows and support growth, while noting that performance may be affected by market and policy uncertainties." datetime: "2026-04-20T22:46:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283409246.md) - [en](https://longbridge.com/en/news/283409246.md) - [zh-HK](https://longbridge.com/zh-HK/news/283409246.md) --- # 160 Health Expands “160AI Hospital” Network to 102 Public Institutions in China ### Claim 30% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks 160 Health International Ltd. ( (HK:2656) ) has shared an update. 160 Health International Limited reported that from January 2025 to March 31, 2026, its “160AI Hospital” collaboration model expanded to 102 public medical institutions, up from 82 at the end of 2025. Of these, 54 are Class IIIA and 78 are Class III or above, underscoring strong traction in China’s high-end hospital segment and broad recognition of the Group’s digital healthcare capabilities. The partner hospitals collectively handle about 84.37 million outpatient visits annually and generate around RMB99.7 billion in yearly revenue, highlighting the substantial operational scale underpinning the company’s platform. Management said the model has moved from pilot to large-scale rollout, and the Group is accelerating deployment of its “Medical Digital Staff” AI systems to deepen integration in clinical workflows, further extend its national network, and support high-quality growth of its digital healthcare business, while cautioning that overall performance remains subject to market and policy uncertainties. **More about 160 Health International Ltd.** 160 Health International Limited is a Hong Kong–listed company operating in the digital healthcare and wellness solutions sector. Its core offerings include the “160AI Hospital” operational collaboration model and related AI-enabled systems, aimed at supporting the digital transformation and intelligent upgrading of public medical institutions, particularly higher-tier Class III hospitals across China. **Average Trading Volume:** 1,075,055 **Technical Sentiment Signal:** Strong Sell **Current Market Cap:** HK$11.91B For a thorough assessment of 2656 stock, go to TipRanks’ Stock Analysis page. ### Related Stocks - [02656.HK](https://longbridge.com/en/quote/02656.HK.md) - [159938.CN](https://longbridge.com/en/quote/159938.CN.md) - [512010.CN](https://longbridge.com/en/quote/512010.CN.md) - [159929.CN](https://longbridge.com/en/quote/159929.CN.md) ## Related News & Research - [Zenoti Expands Its AI Workforce: Purpose-Built AI Agents for Every Medspa Workflow](https://longbridge.com/en/news/284427875.md) - [CMS extends application deadlines for Medicaid drug pricing model](https://longbridge.com/en/news/284622334.md) - [ZAWYA: Cambridge Health Group expands Jeddah Hospital to 200 beds](https://longbridge.com/en/news/284332264.md) - [00:56 ETDentScribe Is Not Just an AI Scribe; It Supports the Entire Dental Day](https://longbridge.com/en/news/284494668.md) - [InHand Networks Launches "Made in Canada" IR624 5G Industrial Router to Power Critical Infrastructure](https://longbridge.com/en/news/284138282.md)